Product Information
BANOPHEN 50 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.0316 per EA under NDC 00904530760. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
50 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904530760
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
11/2/2009
Pharmacological Classes
Price Statistics
The NADAC for BANOPHEN 50 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 60.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0316 per EA |
|---|---|
| All-time high | $0.0316 (Jun 24, 2026) |
| All-time low | $0.0176 (May 19, 2021) |
| 52-week high | $0.0316 |
| 52-week low | $0.0219 |
| Median price | $0.0224 |
| Average price | $0.0223 |
| Largest weekly change | +35.2% (Feb 23, 2022) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BANOPHEN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BANOPHEN 50 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.0316 per EA (NDC 00904530760), effective Jun 24, 2026.
How has the price of BANOPHEN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BANOPHEN 50 MG CAPSULE has risen 60.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BANOPHEN 50 MG CAPSULE?
Since Nov 28, 2013, the NADAC for BANOPHEN 50 MG CAPSULE has ranged from a low of $0.0176 (May 19, 2021) to a high of $0.0316 (Jun 24, 2026), with a median of $0.0224 per EA.
Are there cheaper alternatives to BANOPHEN 50 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BANOPHEN 50 MG CAPSULE, but none are currently priced below it.
Who manufactures BANOPHEN 50 MG CAPSULE?
BANOPHEN 50 MG CAPSULE (NDC 00904530760) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification